The incorporation of individuals aged 10 years and older, considered a high-risk group, alongside biomarkers including ALT, GGT, Hcy, SOD, and PLT—associated with hepatic injury, oxidative stress, and renal/metabolic dysfunction—establishes a multifaceted framework for dyslipidemia risk stratification in WD. The gene discussed is GPT; the disease is metabolic syndrome.